Update on ASCCP Consensus Guidelines for Abnormal Cervical Screening Tests and Cervical Histology | AAFP
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology - ScienceDirect
Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis | Scientific Reports
CERVICAL DYSPLASIA IN PREGNANCY
4236-4242-CIN2/3 lesions during pregnancy
ABNORMAL PAP SMEAR TRIAGE
Cervical Cancer Screening in Pregnancy
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Is pregnancy possible in women diagnosed with cervical dysplasia?
Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience
Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone-length and preterm delivery: a register-based study from western Sweden | BMC Medicine | Full Text
Adverse Pregnancy Outcomes Reported for Women Diagnosed With CIN 3 - Consumer Health News | HealthDay
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3) - Gynecologic Oncology
Case Presentations: Pre-Invasive Cervical Neoplasia - ppt video online download
PDF) Case Report Conservative Approach in a Patient with Cervical Intraepithelial Neoplasia Type-3 (CIN 3) in Pregnancy: Impact on Disease Progression and Pregnancy Outcome CASE REPORT
CERVICAL DYSPLASIA IN PREGNANCY
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors